$CAL

Caleres reported a 6.3% sales decline at Famous Footwear in Q2, with comparable sales down 5.9%. The company closed 18 stores, citing lower traffic and changing consumer preferences. Meanwhile, its Brand Portfolio segment saw a 23.6% sales increase, driven by the Stuart Weitzman acquisition. Caleres expects Famous Footwear sales to continue declining, while Brand Portfolio is projected to grow.

Caleres (CAL) reported Q2 2026 results with net sales up 5.6% YoY to $695.5M, but organic sales excluding Stuart Weitzman declined 0.8%. Brand Portfolio sales grew 8.2% with margin expansion, while Famous Footwear sales fell 6.3%. Adjusted EPS rose to $0.47. The company raised full-year EPS guidance to $1.50-$1.65. Management highlights strategic shift to premium brands and higher-margin channels.

Caleres (CAL) reported Q2 net sales of $695.5M, up 5.6%, and adjusted EPS of $0.47, up from $0.35. Its brand portfolio, including Sam Edelman and Stuart Weitzman, saw sales rise 23.6%, while Famous Footwear sales fell 6.3%. The company raised its full-year guidance but cited inventory and tariff uncertainties.

Famous Footwear, owned by Caleres, reported a 6.3% net sales decline in Q2 2026, with comparable sales down 5.9%. CEO Jay Schmidt attributed this to weaker demand for lifestyle athletic shoes and a late back-to-school start. However, fashion footwear brands like Jordan, Birkenstock, and Brooks performed well, with fashion comps outperforming athletic by over 10 points. The company plans to expand fashion assortment and increase inventory investment to support demand, aiming for sales improvement

Caleres (CAL) reported Q2 sales growth across its brands, with Sam Edelman up mid-teens, Allen Edmonds low teens, and Naturalizer high single digits. Vionic saw sales decline but earnings increased. Stuart Weitzman integration is progressing. Famous Footwear faced athletic category pressure, with sales down 6.3%. Caleres updated guidance, raising the lower end of its full-year adjusted EPS outlook to $1.50-$1.65.

Caleres Inc (CAL) reported Q2 earnings of $0.47 per share, beating estimates of $0.37, and raised FY26 EPS guidance. Shares rose 14.4% to $13.76. Other companies like Opus Genetics (IRD), Signet Jewelers (SIG), and Flotek Industries (FTK) also saw significant gains due to positive updates.

Caleres Inc. (CAL) reported a surge in Q2 profit and revenue, and raised its FY26 earnings forecast. Q3 sales are expected to increase slightly, with EPS projected at $0.62-$0.70. Shares gained 7.05% in pre-market trading. Famous Footwear sales are down, but Brand Portfolio sales are up.

Caleres (CAL) reported Q2 2026 net sales of $695.5M, up 5.6% YoY. Brand Portfolio sales rose 23.6%, while Famous Footwear sales fell 6.3%. GAAP EPS was $1.71, exceeding guidance. The company expects low-single-digit sales growth in Q3 and FY 2026, with improved gross margins.

CALERES INC (CAL) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 September 9, 2026 ​ Caleres Reports Second Quarter 2026 Results Second quarter adjusted EPS exceeds expectations; Brand Portfolio delivers strong organic growth and margin expansion. ​ ● Reported second quarter net sales of $695.5 million, up 5.6%. o Brand Portfolio

Shares of athletic and apparel companies fell after Dick's Sporting Goods reported weaker earnings and reduced its full-year profit outlook, citing rising inventory and promotional discounting. Figs (FIGS), Funko (FNKO), Caleres (CAL), Nike (NKE), and Genesco (GCO) were among the affected stocks, with declines ranging from 2.6% to 3.8%. Figs reported strong Q2 2026 results, with revenue up 28.8% and adjusted EPS beating estimates.